Senior Data Engineer
Rad AI145,000 - 190,000 USD/year
- Full Time
- Senior (5 to 8 years)
Not SpecifiedCompensation
Senior (5 to 8 years), Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Biotechnology, AI & Data ScienceIndustries
Requirements
Candidates must possess a minimum of 8 years of related experience, holding a Bachelor’s degree or equivalent, or 6 years with a Master’s degree, or 3 years with a PhD; they should demonstrate a proven ability to design flexible and maintainable ETL systems, experience with data pipeline orchestration tools like Prefect, Airflow, Argo, Databricks, or Spark, and a solid understanding of the ML model lifecycle, with prior work in scientific or ML workflows being advantageous. Hands-on experience with multi-terabyte scale data processing and familiarity with AWS and Kubernetes is also required, along with knowledge of data lake technologies such as Parquet, Iceberg, and AWS Glue. Strong Python software engineering skills are essential, and a pragmatic mindset to evaluate tradeoffs and empower ML researchers is desired.
Responsibilities
The Software Data Engineer will design and improve data pipelines to transform large, multi-modal datasets into training datasets for AI models, evolve the data storage layer to support analytics, schema evolution, reproducibility, and efficient data access, collaborate with ML engineers to improve the performance and reliability of Python-based data processing workflows, collaborate on the creation, testing, and maintenance of software systems, conduct code reviews for pull requests, maintain and mentor in software best practices, including version control, testing, and documentation, and clearly communicate work in meetings and company demos to an appropriate audience.
Skills
ETL Design
Data pipeline orchestration (Prefect, Airflow, Argo, Databricks, Spark)
ML lifecycle understanding
Multi-terabyte data processing
AWS
Kubernetes
Data lake technologies (Parquet, Iceberg, AWS Glue)
Python
Axsome Therapeutics Inc
Develops therapies for CNS disorders
About Axsome Therapeutics Inc
Axsome Therapeutics develops therapies for central nervous system (CNS) disorders, focusing on conditions like major depressive disorder, treatment-resistant depression, and Alzheimer's agitation. Their main product, AXS-05, is an oral medication that works by blocking NMDA receptors in the brain, which helps regulate mood. This drug has shown positive results in clinical trials and has received special FDA status to speed up its approval process. Unlike many competitors, Axsome emphasizes addressing unmet medical needs in CNS disorders and aims to improve patient outcomes through rigorous research and development. The company's goal is to bring effective treatments to market, enhancing the quality of life for patients suffering from these conditions.
Key Metrics
New York City, New YorkHeadquarters
2012Year Founded
$430.7MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees